Prospective study to measure the impact of MMprofiler on treatment intention in newly diagnosed multiple myeloma patients (PROMMIS).

Parameswaran Hari,Suzanne Lentzsch,David S. Siegel,Saad Z. Usmani,Binod Dhakal,Adriana C Rossi,Cara A. Rosenbaum,Siyang Leng,Divaya Bhutani,Noa Biran,David H. Vesole,Manisha Bhutani,Lisette Stork-Sloots,Femke A. de Snoo,Belinda Dumee,Martin H. van Vliet,Ruben Niesvizky

Prospective study to measure the impact of MMprofiler on treatment intention in newly diagnosed multiple myeloma patients (PROMMIS).

2019

Parameswaran Hari
Suzanne Lentzsch
David S. Siegel
Saad Z. Usmani
Binod Dhakal
Adriana C Rossi
Cara A. Rosenbaum
Siyang Leng
Divaya Bhutani
Noa Biran
David H. Vesole
Manisha Bhutani
Lisette Stork-Sloots
Femke A. de Snoo
Belinda Dumee
Martin H. van Vliet
Ruben Niesvizky

8030Background: Multiple Myeloma (MM) is recognized as a heterogeneous group of patients with varying response and outcome of their disease, associated with various risk factors including genetic a...

Keywords:

Physical therapy
Disease
Prospective cohort study
Medicine
Internal medicine
Multiple myeloma
newly diagnosed
heterogeneous group

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations